Renal
Syner-Med first developed and introduced IV Iron Sucrose to Renal Units across the UK in 1994. Since this time, Syner-Med has successfully developed a strong presence and relationship within the Renal arena.
Today, Chronic Kidney Disease (CKD), the progressive loss of kidney function, affects 50million people in the U.S. and Europe alone. Syner-Med provides Renal Units across the world with Catheter Management products to improve Clinical Outcomes and enhance patient welfare.
Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine. Adverse events should also be reported to Syner-Med (Pharmaceutical Products) Limited. Tel. +44 020 8655 6380
